Furthermore, G‐749 is screened and identified as a novel NAT10 inhibitor capable of effectively impeding lysosomal acidification and tumor metastasis by disrupting the NAT10‐Ubiquitin‐specific Peptidase 39 (USP39) interaction. The gene discussed is USP39; the disease is neoplasm.